IVI, Bharat Biotech Begin Chikungunya Vaccine Phase-II/III Trials in Costa Rica
The International Vaccine Institute or IVI and Bharat Biotech International Ltd or BBIL have begun the phase-II /III trials of […]
The International Vaccine Institute or IVI and Bharat Biotech International Ltd or BBIL have begun the phase-II /III trials of […]
Zydus Cadila and Takeda Pharmaceutical have entered into partnership to develop the first vaccine to treat chikungunya virus infection. The […]